Found 289 articles for: "skin of color"
FULL SUPPLEMENT: Prebiotic Skincare Management of Atopic Dermatitis & Xerosis in Diverse Ethnically Patients
March 2024 | Volume 23 | Issue 3 | Department | SF395747s1 | Copyright © March 2024
Atopic Dermatitis (AD) is a chronic relapsing inflammatory skin disease associated with a significant patient burden on quality-of-life. Rising evidence demonstrate skin microbiome playing an essentia...
Read MoreINDIVIDUAL ARTICLE: Recent Advances in Skincare Management of Atopic Dermatitis in Diverse Racial and Ethnic Groups
March 2024 | Volume 23 | Issue 3 | Supplement Individual Articles | SF395747s4 | Copyright © March 2024
INDIVIDUAL ARTICLE: Atopic Dermatitis Skincare and Impact on Quality of Life for Patients with Skin of Color
March 2024 | Volume 23 | Issue 3 | Supplement Individual Articles | SF395747s6 | Copyright © March 2024
Atopic Dermatitis (AD) epidemiologic studies report a higher incidence and prevalence among populations with skin of color (SOC). Additionally, differences in AD underlying gene mutations and ski...
Read MoreINDIVIDUAL ARTICLE: Efficacy of a Prebiotic Skincare Regimen on Improving Mild Atopic Dermatitis and Severe Xerosis in Diverse Ethnically Patients
March 2024 | Volume 23 | Issue 3 | Supplement Individual Articles | SF395747s12 | Copyright © March 2024
Atopic dermatitis (AD) is a chronic relapsing inflammatory skin disease associated with a significant patient burden on quality of life. Given skin barrier including skin microbiome changes are l...
Read MoreMicroneedling for Treatment of Acne Scars: Considerations on the Successful Management of This Aesthetic Procedure
March 2024 | Volume 23 | Issue 3 | Editorials | e79 | Copyright © March 2024
First Use of Combination Oral Deucravacitinib With Tapinarof Cream for Treatment of Severe Plaque Psoriasis
March 2024 | Volume 23 | Issue 3 | Case Reports | 192 | Copyright © March 2024
Plaque psoriasis is a chronic, immune-mediated, cutaneous, and systemic inflammatory dermatosis. Its pathogenesis involves the dysregulation of the interleukin (IL)-23/IL-17 signaling pathway. Th...
Read MoreINDIVIDUAL ARTICLE: Impact of Acne Vulgaris and Sarecycline on Social/Emotional Functioning and Daily Activities: PROSES Study
February 2024 | Volume 23 | Issue 2 | Supplement Individual Articles | SF405634s5 | Copyright © February 2024
Background: Concise patient-reported outcome (PRO) instruments addressing the consequences of facial acne vulgaris (AV) on patients’ functioning and activities of daily liv...
Read MoreINDIVIDUAL ARTICLE: Assessing the Impact of Acne and Its Treatment on Disease Burden and Quality of Life
February 2024 | Volume 23 | Issue 2 | Supplement Individual Articles | SF405634s4 | Copyright © February 2024
Outcomes for Psoriasis by Self-Identified Racial Groups in Ixekizumab Clinical Trials: A Pooled Analysis
February 2024 | Volume 23 | Issue 2 | Original Article | 17 | Copyright © February 2024
Background: Biologics have shown promising outcomes in psoriasis clinical trials. However, there is a paucity of data exploring the potential differences in outcomes between self...
Read MoreThe Pediatric Dermatologist's View of Pediatric Vitiligo
February 2024 | Volume 23 | Issue 2 | Editorials | e77 | Copyright © February 2024
Background: No guidelines exist for pediatric vitiligo.Objective: To identify practice patterns of pediatric dermatologists treating vitiligo....
Read MoreAtypical Dyschromia in Skin of Color
February 2024 | Volume 23 | Issue 2 | Case Reports | 100 | Copyright © February 2024
Dyschromia is a concern for many patients, especially persons of color. Postinflammatory hypopigmentation and depigmentation can affect all skin types; however, it is more apparent in those with ...
Read MoreComparing the Efficacy and Tolerability of Moderate to Severe Hyperpigmentation and Skin Unevenness
January 2024 | Volume 23 | Issue 1 | Original Article | 1260 | Copyright © January 2024
Dyschromia is the result of irregular facial pigmentation. These cutaneous manifestations can have a significant impact on the quality of life of those affected, especially among females and skin...
Read MoreOptimized Patient Outcomes With the Novel Modality of Corrective Chemical Peel and Neurotoxin on Same-Day Treatment
January 2024 | Volume 23 | Issue 1 | Original Article | 1349 | Copyright © January 2024
Background: This study was conducted to improve standards of care in the cosmetic treatment of sun damage, fine lines, and wrinkles. Chemical Peels and Neurotoxins have been trad...
Read MoreThe Importance of Photoaging Prevention in All Skin Types: An Update on Current Advancements
January 2024 | Volume 23 | Issue 1 | Original Article | 1306 | Copyright © January 2024
Light from across the electromagnetic spectrum, including ultraviolet, visible, and infrared light, can cause detrimental cutaneous effects including photocarcinogenesis and photoaging. Tradition...
Read MoreINDIVIDUAL ARTICLE: Patient Journey and the Burden of Systemic Comorbidities and Sequalae in Prurigo Nodularis
December 2023 | Volume 22 | Issue 12 | Supplement Individual Articles | SF365502s12 | Copyright © December 2023
Background: Prurigo Nodularis (PN) is a relatively rare chronic inflammatory skin disease characterized by firm pruritic nodules. PN is associated with significantly increased ra...
Read MoreINDIVIDUAL ARTICLE: Prurigo Nodularis: Current Clinicopathologic Overview and Psychodermatological Perspectives
December 2023 | Volume 22 | Issue 12 | Supplement Individual Articles | SF365502s6 | Copyright © December 2023
Prurigo nodularis (PN) is a quintessential neurocutaneous condition characterized by neural sensitization and intractable itch leading to intense scratching. This causes the formation of nodules ...
Read MoreINDIVIDUAL ARTICLE: Pediatric Atopic Dermatitis Patient Cases Integrating Ceramides-Containing Cleansers and Moisturizers into Prescription Treatment and Maintenance Approaches
December 2023 | Volume 22 | Issue 12 | Supplement Individual Articles | SF389716s3 | Copyright © December 2023
Introduction: Atopic dermatitis (AD) is a common, chronic recurrent disorder typically starting in infancy and early childhood and associated with pruritus and genetic predisposi...
Read MoreInternational Dermatology Outcome Measures (IDEOM) - Report from the 2022 Annual Meeting
December 2023 | Volume 22 | Issue 12 | Original Article | 1153 | Copyright © December 2023
Background: The International Dermatology Outcome Measures (IDEOM) is a non-profit organization dedicated to the advancement of evidence-based, consensus-driven outcome measures ...
Read MoreUnderrepresented Groups and Perceived Educational Barriers for Residency and Fellowship Success
December 2023 | Volume 22 | Issue 12 | Original Article | 1210 | Copyright © December 2023
Background: The study aimed to compare barriers perceived by medical students and resident physicians identifying as of underrepresented groups in medicine (UIM) and/or as sexual...
Read MoreMpox "Monkeypox" Virus: The Importance of Inclusive Imagery to Prevent Disease Stigma
December 2023 | Volume 22 | Issue 12 | Editorials | 1235 | Copyright © December 2023
Since the initial coverage of the monkeypox virus, there has been debate among physicians over how to responsibly communicate public health information without harming historically marginalized commun...
Read MoreMedia and other results for: "skin of color"